Cardiac infections: focus on molecular diagnosis

Cardiovascular Pathology

Volumn 19, Issue 3, 2010, Pages 171-182

  Calabrese, Fiorella ^a   Carturan, Elisa ^a   Thiene, Gaetano ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Endocarditis; Molecular techniques; Myocarditis; Pericarditis

Indexed keywords

BACTERIAL DNA; BETA INTERFERON; IMMUNOSUPPRESSIVE AGENT; RNA 16S; TUMOR NECROSIS FACTOR ALPHA;

CARDITIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG SAFETY; ENDOCARDITIS; GENE SEQUENCE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HUMAN; IN SITU HYBRIDIZATION; MICROBIAL IDENTIFICATION; MOLECULAR DYNAMICS; MYCOBACTERIUM TUBERCULOSIS; MYOCARDITIS; NONHUMAN; PATIENT CARE; PERICARDITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SEQUENCE ANALYSIS; SLOT BLOT HYBRIDIZATION; TREATMENT OUTCOME; VIRUS MYOCARDITIS;

CARDIOVASCULAR INFECTIONS; HUMANS; MOLECULAR BIOLOGY;

EID: 77951879744     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2009.09.010     Document Type: Review

References (112)

1. Butany J. The pericardium and its diseases. In: Silver D.M. (Ed). Cardiovascular pathology (1991), Churchill Livingstone, New York 847-894
2. Friman G., and Fohlman J. The epidemiology of viral heart disease. Scand J Infect Dis Suppl 88 (1993) 7-10
3. Barbaro G., and Klatt E.C. HIV infection and the cardiovascular system. AIDS Rev 4 (2002) 93-103
4. Spodick D.H. Acute pericarditis: current concepts and practice. JAMA 289 (2003) 1150-1153
5. Troughton RW., Asher C.R., and Klein A.L. Pericarditis. Lancet 363 (2004) 717-727
6. Maisch B., Seferović P.M., Ristić A.D., Erbel R., Rienmüller R., Adler Y., et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J 25 (2004) 587-610
7. Oh K.Y., Shimizu M., Edwards W.D., Tazelaar H.D., and Danielson G.K. Surgical pathology of the parietal pericardium: a study of 344 cases (1993-1999). Cardiovasc Pathos 10 (2001) 157-168
8. Maisch B., and Ristic A.D. The classification of pericardial disease in the age of modern medicine. Curr Cardiol Rep 4 (2002) 13-21
9. Lorbar M., and Spodick DH. 'Idiopathic' pericarditis-the clinician's challenge. [nothing is idiopathic]. Int J Clin Pract 61 (2007) 138-142
10. Levy P.Y., Fournier P.E., Charrel R., Metras D., Habib G., and Raoult D. Molecular analysis of pericardial fluid: a 7-year experience. Eur Heart J 27 (2006) 1942-1946
11. Permanyer-Miralda G., Sagristá-Sauleda J., and Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 56 (1985) 623-630
12. Maisch B., Risti A.D., and Seferovi P.M. New directions in diagnosis and treatment of pericardial disease: an update by the Taskforce on pericardial disease of the World Heart Federation. Herz 25 (2000) 769-780
13. Estok L., and Wallach F. Cardiac tamponade in a patient with AIDS: a review of pericardial disease in patients with HIV infection. Mt Sinai J Med 65 (1998) 33-39
14. Wragg A., and Strang J.I. Tuberculous pericarditis and HIV infection. Heart 84 (2000) 127-128
15. Tiruviluamala P., and Reichman L.B. Tuberculosis. Annu Rev Public Health 23 (2002) 403-426
16. Desai H.N. Tuberculous pericarditis. A review of 100 cases. S Afr Med J 55 (1997) 877-880
17. Koh K.K., Kim E.J., Cho C.H., Choi M.J., Cho S.K., Kim S.S., et al. Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis. Circulation 89 (1994) 2728-2735
18. Bogard M., Vincelette J., Antinozzi R., Alonso R., Fenner T., Schirm J., et al. Multicenter study of a commercial, automated polymerase chain reaction system for the rapid detection of Mycobacterium tuberculosis in respiratory specimens in routine clinical practice. Eur J Clin Microbiol Infect Dis 20 (2001) 724-731
19. Hasaneen N.A., Zaki M.E., Shalaby H.M., and El-Morsi A.S. Polymerase chain reaction of pleural biopsy is a rapid and sensitive method for the diagnosis of tuberculous pleural effusion. Chest 124 (2003) 2105-2111
20. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., et al. Report of the 1995 WHO/ISFC task force on the definition of cardiomyopathies. Circulation 93 (1996) 841-842
21. Dec G.W., Palacios I.F., Fallon J.T., Aretz H.T., Mills J., Lee D.C., et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med 312 (1985) 885-890
22. Basso C., Calabrese F., Corrado D., and Thiene G. Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc Res 50 (2001) 290-300
23. Martin A.B., Webber S., Fricker F.J., Jaffe R., Demmler G., Kearney D., et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 90 (1994) 330-339
24. Calabrese F., Rigo E., Milanesi O., Boffa G.M., Angelini A., Valente M., et al. Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol 11 (2002) 212-221
25. Dennert R., Crijns H.J., and Heymans S. Acute viral myocarditis. Eur Heart J 29 (2008) 2073-2082
26. Baughman K.L. Diagnosis of myocarditis: death of Dallas criteria. Circulation 113 (2006) 593-595
27. Cooper L.T., Baughman K.L., Feldman A.M., Frustaci A., Jessup M., Kuhl U., et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 28 (2007) 3076-3093
28. Woodruf J.F. Viral myocarditis: a review. Am J Pathol 101 (1980) 425-484
29. Gauntt C., Godeney E., Lutton A., et al. Mechanism(s) of coxsackievirus-induced myocarditis in the mouse. In: de la Maza L., and Pterson E. (Eds). Medical virology. 8th ed. (1988), Lawrence Erlbaum, Hillsdale (NJ) 161-182
30. Rotbart H. Human enterovirus infections: molecular approaches to diagnosis and pathogenesis. In: Semler B., and Ehrenfeld E. (Eds). Molecular aspects of picornavirus infection and detection (1989), American Society for Microbiology, Washington (DC) 243-264
31. Bowles N.E., Richardson P.J., Olsen E.G., and Archard L.C. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1 (1986) 1120-1123
32. Schmaltz A.A., Apitz J., Hort W., and Maisch B. Endomyocardial biopsy in infants and children: experience in 60 patients. Pediatr Cardiol 11 (1990) 15-21
33. Pophal S.G., Sigfusson G., Booth K.L., Bacanu S.A., Webber S.A., Ettedgui J.A., et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 34 (1999) 2105-2110
34. Akhtar N., Ni J., Stromberg D., Rosenthal G.L., Bowles N.E., and Towbin J.A. Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis. Circulation 99 (1999) 2011-2018
35. Carturan E., Milanesi O., Kato Y., Giacometti C., Biffanti R., Thiene G., et al. Viral detection and tumor necrosis factor alpha profile in tracheal aspirates from children with suspicion of myocarditis. Diagn Mol Pathol 17 (2008) 21-27
36. Matsumori A., Matoba Y., and Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 92 (1995) 2519-2525
37. Schonian U., Crombach M., Maser S., and Maisch B. Cytomegalovirus-associated heart muscle disease. Eur Heart J S 16 (1995) 46-49
38. Klingel K., Selinka H.C., Sauter M., Bock C.T., Szalay G., and Kandorlf R. Molecular mechanisms in enterovirus and parvovirus B19 associated myocarditis and inflammatory cardiomyopathy. Eur J S 4 (2002) 9-12
39. Kühl U., Pauschinger M., Noutsias M., Seeberg B., Bock T., Lassner D., et al. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 1117 (2005) 887-893
40. Caforio A.L., Calabrese F., Angelini A., Tona F., Vinci A., Bottaro S., et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28 (2007) 1326-1333
41. Mahrholdt H., Goedecke C., Wagner A., Meinhardt G., Athanasiadis A., Vogelsberg H., et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109 (2004) 1250-1258
42. Donoso Mantke O., Meyer R., Prösch S., Nitsche A., Leitmeyer K., Kallies R., et al. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool. J Heart Lung Transplant 24 (2005) 1632-1638
43. Schenk T., Enders M., Pollak S., Hahn R., and Huzly D. High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol 47 (2009) 106-110
44. Wang X., Zhang G., Liu F., Han M., Xu D., and Zang Y. Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization. J Clin Virol 31 (2004) 20-24
45. Murry C.E., Jerome K.R., and Reichenbach D.D. Fatal parvovirus myocarditis in a 5-year-old girl. Hum Pathol 32 (2001) 342-345
46. Preston F.E., Jarvis L.M., Makris M., Philp L., Underwood J.C., Ludlam C.A., et al. Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease. Blood 85 (1995) 1259-1262
47. Estrin M., Smith C., and Huber S. Antigen-specific suppressor T cells prevent cardiac injury in BALB/c mice infected with a nonmyocarditic variant of coxsackievirus group B, type 3. AmJ Pathol 125 (1986) 578-584
48. Selinka H.C., Wolde A., Pasch A., Klingel K., Schnorr J.J., Kupper J.H., et al. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis. J Med Virol 67 (2002) 224-233
49. Chapman N.M., Tu Z., Tracy S., and Gauntt C.J. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch Virol 135 (1994) 115-130
50. Cameron-Wilson C.L., Pandolfino Y.A., Zhang H.Y., Pozzeto B., and Archard L.C. Nucleotide sequence of an attenuated mutant of coxsackievirus B3 compared with the cardiovirulent wildtype: assessment of candidate mutations by analysis of a revertant to cardiovirulence. Clin Diagn Virol 9 (1998) 99-105
51. Dunn J.J., Chapman N.M., Tracy S., and Romero J.R. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5′ non-translated region. J Virol 74 (2000) 4787-4794
52. Höfling K., Kim K.S., Leser J.S., Chapman N.M., Willian S., Gauntt C.J., and Tracy S. Progress toward vaccines against virus that cause heart disease. Herz 25 (2000) 286-290
53. Lam K.M., Oldenburg N., Khan M.A., Gaylore V., Mikhail G.W., Strouhal P.D., et al. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients. J Heart Lung Transplant 17 (1998) 555-565
54. Pauschinger M., Bowles N.E., Fuentes-Garcia F.J., Pham V., Kühl U., Schwimmbeck P.L., et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99 (1999) 1348-1354
55. Mason J.W. Myocarditis and dilated cardiomyopathy: and inflammatory link. Cardiovasc Res 60 (2003) 5-10
56. Matsumori A. Cytokines in myocarditis and cardiomyopathies. Curr Opin Cardiol 11 (1996) 302-309
57. Calabrese F., Carturan E., Chimenti C., Pieroni M., Agostini C., Angelini A., et al. Overexpression of tumor necrosis factor (TNF)alpha and TNFalpha receptor I in human viral myocarditis: clinicopathologic correlations. Mod Pathol 17 (2004) 1108-1118
58. Why H.J., Meany B.T., Richardson P.J., Olsen E.G., Bowles N.E., Cunningham L., et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89 (1994) 2582-2589
59. Figulla H.R., Stille-Siegener M., Mall G., Heim A., and Kreuzer H. Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 25 (1995) 1170-1175
60. Fujioka S., Kitaura Y., Ukimura A., Deguchi H., Kawamura K., Isomura T., et al. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 36 (2000) 1920-1926
61. Shirali G.S., Ni J., Chinnock R.E., Johnston J.K., Rosenthal G.L., Bowles N.E., et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 344 (2000) 1498-1503
62. Bowles N.E., Ni J., Kearney D.L., Pauschinger M., Schultheiss H.P., McCarthy R., Hare J., et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42 (2003) 466-472
63. Kuethe F., Sigusch H.H., Hilbig K., Tresselt C., Glück B., Egerer R., et al. Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy. Am Heart J 153 (2007) 850-885
64. Kindermann I., Kindermann M., Kandolf R., Klingel K., Bültmann B., Müller T., et al. Predictors of outcome in patients with suspected myocarditis. Circulation 118 (2008) 639-648
65. Kühl U., Pauschinger M., Schwimmbeck P.L., Seeberg B., Lober C., Noutsias M., et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107 (2003) 2793-2798
66. Daliento L., Calabrese F., Tona F., Caforio A.L., Tarsia G., Angelini A., et al. Successful treatment of enterovirus-induced myocarditis with interferon-alpha. J Heart Lung Transplant 22 (2003) 214-217
67. Mason J.W., O'Connell J.B., and Herskowitz A. A clinical trial of immunosuppressive and immunomodulatory treatment for myocarditis. N Engl J Med 333 (1995) 269-275
68. Maish B., Hufnagel G., Schonian U., Hengstenberg C., and for the ESETCID investigators. The European study of epidemiology and treatment of cardiac inflammatory disease (ESETCID). Eur Heart J S16 (1995) 172-175
69. Frustaci A., Calabrese F., Chimenti C., Pieroni M., Thiene G., and Maseri A.A. Immunosopressive therapy for active lymphocythic myocarditis: virologic and immunologic profile of responders versus non responders. Circulation 107 (2003) 857-863
70. Wojnicz R., Nowalany-Kozielska E., Wojciechowska C., Glanowska G., Wilczewski P., Niklewski T., et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104 (2001) 39-45
71. Horstkotte D., Follath F., Gutschik E., Lengyel M., Oto A., Pavie A., et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25 (2004) 267-276
72. Thiene G., and Basso C. Pathology and pathogenesis of infective endocarditis in native heart valves. Cardiovasc Pathol 15 (2006) 256-263
73. Silver M.D. Infective endocarditis. In: Silver M.D. (Ed). Cardiovascular pathology (1991), Churchill Livingstone, New York 895-932
74. Prendergast B.D. The changing face of infective endocarditis. Heart 92 (2006) 879-885
75. Hoen B. Epidemiology and antibiotic treatment of infective endocarditis: an update. Heart 92 (2006) 1694-1700
76. Mylonakis E., and Calderwood S.B. Infective endocarditis in adults. N Engl J Med 345 (2001) 1318-1330
77. Beynon R.P., Bahl V.K., and Prendergast B.D. Infective endocarditis. BMJ 333 (2006) 334-339
78. Millar B.C., and Moore J.E. Antibiotic prophylaxis, body piercing and infective endocarditis. J Antimicrob Chemother 53 (2004) 123-126
79. Valencia E., and Miró J. Endocarditis in the setting of HIV infection. AIDS Rev 6 (2004) 97-106
80. Durack D.T., Lukes A.S., and Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96 (1994) 200-209
81. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler V.G., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30 (2000) 633-638
82. Millar B.C., and Moore J.E. Current trends in the molecular diagnosis of infective endocarditis. Eur J Clin Microbiol Infect Dis 23 (2004) 353-365
83. Goldenberger D., Künzli A., Vogt P., Zbinden R., and Altwegg M. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 35 (1997) 2733-2739
84. Millar B., Moore J., Mallon P., Xu J., Crowe M., Mcclurg R., et al. Molecular diagnosis of infective endocarditis-a new Duke's criterion. Scand J Infect Dis 33 (2001) 673-680
85. Moore J.E., Millar B.C., Yongmin X., Woodford N., Vincent S., Goldsmith C.E., et al. Molecular identification of Acinetobacter sp. in a patient with culture-negative endocarditis. Clin Microbiol Infect 6 (2000) 277-278
86. Hryniewiecki T., Gzyl A., Augustynowicz E., and Rawczynska-Englert I. Development of broad-range polymerase chain reaction (PCR) bacterial identification in diagnosis of infective endocarditis. J Heart Valve Dis 11 (2002) 870-874
87. Grijalva M., Horváth R., Dendis M., Erný J., and Benedík J. Molecular diagnosis of culture negative infective endocarditis: clinical validation in a group of surgically treated patients. Heart 89 (2003) 263-268
88. Bosshard P.P., Kronenberg A., Zbinden R., Ruef C., Böttger E.C., and Altwegg M. Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis 37 (2003) 167-172
89. Gauduchon V., Chalabreysse L., Etienne J., Célard M., Benito Y., Lepidi H., et al. Molecular diagnosis of infective endocarditis by PCR amplification and direct sequencing of DNA from valve tissue. J Clin Microbiol 41 (2003) 763-766
90. Podglajen I., Bellery F., Poyart C., Coudol P., Buu-Hoï A., Bruneval P., et al. Comparative molecular and microbiologic diagnosis of bacterial endocarditis. Emerg Infect Dis 9 (2003) 1543-1547
91. Lang S., Watkin R.W., Lambert P.A., Bonser R.S., Littler W.A., and Elliott T.S. Evaluation of PCR in the molecular diagnosis of endocarditis. J Infect 48 (2004) 269-275
92. Lang S., Watkin R.W., Lambert P.A., Littler W.A., and Elliott T.S. Detection of bacterial DNA in cardiac vegetations by PCR after the completion of antimicrobial treatment for endocarditis. Clin Microbiol Infect 10 (2004) 579-581
93. Greub G., Lepidi H., Rovery C., Casalta J.P., Habib G., Collard F., et al. Diagnosis of infectious endocarditis in patients undergoing valve surgery. Am J Med 118 (2005) 230-238
94. Breitkopf C., Hammel D., Scheld H.H., Peters G., and Becker K. Impact of a molecular approach to improve the microbiological diagnosis of infective heart valve endocarditis. Circulation 111 (2005) 1415-1421
95. Rovery C., Greub G., Lepidi H., Casalta J.P., Habib G., Collart F., et al. PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol 43 (2005) 163-167
96. Kotilainen P., Heiro M., Jalava J., Rantakokko V., Nikoskelainen J., Nikkari S., et al. Aetiological diagnosis of infective endocarditis by direct amplification of rRNA genes from surgically removed valve tissue. An 11-year experience in a Finnish teaching hospital. Ann Med 38 (2006) 263-273
97. Marín M., Muñoz P., Sánchez M., del Rosal M., Alcalá L., Rodríguez-Créixems M., et al. Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore) 86 (2007) 195-202
98. Voldstedlund M., Nørum Pedersen L., Baandrup U., Klaaborg K.E., and Fuursted K. Broad-range PCR and sequencing in routine diagnosis of infective endocarditis. APMIS 116 (2008) 190-198
99. Lisby G., Gutschik E., and Durack D.T. Molecular methods for diagnosis of infective endocarditis. Infect Dis Clin North Am 16 (2002) 393-412
100. Prendergast B.D. Diagnostic criteria and problems in infective endocarditis. Heart 90 (2004) 611-613
101. Shin G.Y., Manuel R.J., Ghori S., Brecker S., and Breathnach A.S. Molecular technique identifies the pathogen responsible for culture negative infective endocarditis. Heart e47 (2005) 91
102. Ben-Ami R., Giladi M., Carmeli Y., Orni-Wasserlauf R., and Siegman-Igra Y. Hospital-acquired infective endocarditis: should the definition be broadened?. Clin Infect Dis 38 (2004) 843-850
103. Moreillon P., and Que Y.A. Infective endocarditis. Lancet 363 (2004) 139-149
104. Relman D.A., Schmidt T.M., MacDermott R.P., and Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 327 (1992) 293-301
105. Bayer PD, Scheld WM. Endocarditis and intravascular infections. In Mandell GL, Bennett JE, Dolin R (eds.), Principles and practices of infectious diseases, vol. 1, 5th ed. New York, NY: Churchill Livingstone, 2000. p.857-902.
106. Presterl E., Grisold A.J., Reichmann S., Hirschl A.M., Georgopoulos A., and Graninger W. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics. J Antimicrob Chemother 55 (2005) 45-50
107. Chu V.H., Sexton D.J., Cabell C.H., Reller L.B., Pappas P.A., Singh R.K., et al. Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis 41 (2005) 406-409
108. Rothman R.E., Majmudar M.D., Kelen G.D., Madico G., Gaydos C.A., Walker T., et al. Detection of bacteremia in emergency department patients at risk for infective endocarditis using universal 16S rRNA primers in a decontaminated polymerase chain reaction assay. J Infect Dis 186 (2002) 1677-1681
109. Lamas C.C., and Eykyn S.J. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis 25 (1997) 713-719
110. Fournier P.E., Casalta J.P., Habib G., Messana T., and Raoult D. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med 100 (1996) 629-633
111. Houpikian P., and Raoult D. Diagnostic methods current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. Infect Dis Clin North Am 16 (2002) 377-392
112. Lepidi H., Durack D.T., and Raoult D. Diagnostic methods current best practices and guidelines for histologic evaluation in infective endocarditis. Infect Dis Clin North Am 16 (2002) 339-361